Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03348683 · ClinicalTrials.gov registry record · Phase 2

Propranolol Versus Placebo for Induction of Labor in Nulliparous Patients

A Phase 2 study, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
Phase 2
Development phase
240
Enrollment target

NCT03348683: Completed Phase 2 study, sponsored by Icahn School of Medicine at Mount Sinai.

NCT03348683 is a Phase 2 study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 240 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (80% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03348683, a Phase 2 study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
Phase 2
Development phase
240 participants
Enrollment target

Study Summary

A randomized, prospective trial will be offered to women admitted to the labor floors at Mount Sinai Medical Center for labor induction.

Primary Outcome

The time of induction (based on time of foley balloon placement for cervical ripening or misoprostol administration) to the time of delivery of the infant.

Interventions

  • DRUG Placebo
  • DRUG Propranolol

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2017-12-11
Est. Completion 2018-12-11
Phase Phase 2

What the finished NCT03348683 record still lists

NCT03348683 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (80% higher).

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT03348683 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03348683 about?

NCT03348683 is a clinical study titled "Propranolol Versus Placebo for Induction of Labor in Nulliparous Patients". A randomized, prospective trial will be offered to women admitted to the labor floors at Mount Sinai Medical Center for labor induction.

What is the current status of trial NCT03348683?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 240 participants. The study started on 2017-12-11. Estimated completion is 2018-12-11.

What interventions are being tested in trial NCT03348683?

The interventions under investigation include: Placebo (DRUG), Propranolol (DRUG).

Who is sponsoring clinical trial NCT03348683?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03348683's enrollment target sits among peer trials

240 239th of 2000 higher than 1,746 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02855554 · 240 participants · NA

    Quantitative Cardiac Parametric Mapping

  • NCT03230565 · 240 participants · Phase 4

    Continuous Infusions vs Scheduled Bolus Infusions

  • NCT03399929 · 240 participants

    Traumatic Brain Injury and Stroke Long Term Outcome

  • NCT03583710 · 240 participants · Phase 3

    Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03348683, the US trial registry maintained by the National Library of Medicine. NCT03348683 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.